Le Lézard
Classified in: Health
Subject: WOM

Avoiding A Fatal Attraction: Jamie Noel's Story Unfolded


LOS ANGELES, Sept. 13, 2018 /PRNewswire-PRWeb/ -- Attention all women.

You have recently met someone you consider interesting. Now what?

Be aware, Jamie Noel warns women. She's been a victim of months of stalking and harassment since she ended a 16-month relationship from January 2018. She says the threats began in March 2018 after he told her he was a former cryptocurrency billionaire working as a federal informant and threatened to have her killed or arrested if she did not continue to date him.

Now, in hindsight, she says she should have paid more attention to things she dismissed early on, such as:

Jamie Noel wants to warn women: Get to know who you are dating prior to getting involved.

Be aware of all the subtle signs. Do not overlook or dismiss them during the initial period of infatuation.

Jamie wishes she had done this when she first started seeing him in September 2016.

To recap: they broke up in January 2018.

On March 2018, ongoing harassment that she attributes to him began. Constant text messages. Her phone was hacked. Strange people contacted her.

It has not stopped, even though he agreed to do so when she went to see him at his home on April 24, 2018, she reports.

Her Apple ID was used in Westville, Ohio on April 25, 2018 when she was in Los Angeles, California.

In the recording Jamie made on May 15, he denies hacking her phone, says, "I just want to drive you insane." He concludes by adding, "I'm still going to marry you."

As strange as this scenario may be, Jamie Noel's warning will serve many women well.

 

SOURCE Bryce Group


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: